Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

3 hrs ago | Boston.com

Seven things you should know about Amy Schulman

Amy Schulman, who recently left her job as general counsel at Pfizer Inc. in New York, began work this week at Boston venture capital firm Polaris Partners.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

7 hrs ago | BioSpace

Icon: Pfizer Inc. And Roche Join Addplan DF Consortium

ICON plc , today announced that Pfizer and Roche have joined the ADDPLANA DF Consortium.

Comment?

Related Topix: Biotech, ICON, Medicine, Healthcare Industry

12 hrs ago | Reuters

Pfizer says threats to managers force staff lockout at Mumbai factory

Pfizer Ltd, the Indian unit of U.S. drugmaker Pfizer Inc, said on Friday it locked out staff at its Mumbai drug factory after some employees tried to disrupt production lines and threatened management.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, World News, India,

16 hrs ago | Seeking Alpha

Cramer's Lightning Round - I Feel Terrific About Waste Management

Energy Transfer Partners : "I like the yield here at 6.85% with some growth. It is working.

Comment?

Related Topix: Industrial Machines, Precision Castparts, Aerospace-Defense, Metals, Zynga, Biotech, Medicine, Healthcare Industry

Thu Jul 31, 2014

Modern Healthcare

Baxter to offload vaccine business to Pfizer for $635 million

Baxter International is selling its vaccine business to Pfizer for $635 million as it prepares to split into two companies.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Baxter International, E.Factor, Medical Equipment, Deerfield, IL

The Washington Post

AstraZeneca Raises Forecast as Nexium Payment Boosts Profit

AstraZeneca Plc raised its forecast after reporting quarterly profit that beat analyst estimates, helped by a $200 million payment from one-time suitor Pfizer Inc. for rights to an over-the-counter version of the Nexium heartburn treatment.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Heartburn, Health, Business News

The Washington Post

AstraZeneca to Acquire Almirall Lung Drugs for $875 Million

AstraZeneca Plc, the U.K. drugmaker that resisted a Pfizer Inc. takeover attempt, is building up its respiratory business by buying the rights to Almirall SA's lung medicines for $875 million.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pearl Therapeutics, Foradil, Formoterol (generic), Business News

Wed Jul 30, 2014

Seeking Alpha

Pfizer - Guides Lower Again, Uncertainty About The Future Strategy Remains

Pfizer reported second-quarter results which were more or less in line with consensus estimates.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Investopedia

Why There's Far More To Pfizer Than Viagra

In bygone centuries, medicine consisted of bloodletting and leeches. Cures were simple and inexpensive, if petrifying.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Viagra, Sildenafil (generic), Financial Markets, Erectile Dysfunction, Health, Lyrica, Pregabalin (generic)

Sys-Con Media

InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada

Olanzapine is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania.

Comment?

Related Topix: Medicine, Zyprexa, Zydis, Olanzapine (generic), Schizophrenia, Health, Biotech, Healthcare Industry

TheStreet.com

Why Pfizer (PFE) Stock Is Down Today

The acquisition grants Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and encephalitis vaccine, FSME-IMMUN, along with a part of Baxter's Austrian facility that produces the drugs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, TheStreet

Pharmaceutical Processing

Baxter to Sell Commercial Vaccines Business to Pfizer

Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a total cash consideration of $635 million, subject to certain adjustments.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Baxter International, E.Factor, Medical Equipment, Influenza, Health, Lyme Disease

Philly.com

Merck CEO seeks drug add-ons, not large tax-inversion deals

Merck & Co., the second-biggest U.S. drugmaker, is staying in the United States and sticking to a bolt-on acquisition strategy, shunning the route taken by its biggest rival, Pfizer Inc. Merck, maker of the diabetes pill Januvia, is not interested in large-scale purchases that are "very time-consuming and distracting to what we're here to do, which ... (more)

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, North Wales, PA, Lansdale, PA

Barron's

Morning Movers: BP, UPS, Drugmakers

Russia's bad behavior is having an impact on integrated oil giant BP , which warned that increasing Western sanctions on Russia could hurt given its nearly 20% stake in state oil company Rosneft.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Aetna, Insurance, Financial Markets

Tue Jul 29, 2014

Seeking Alpha

Pfizer's (PFE) CEO Ian Read on Q2 2014 Results - Earnings Call Transcript

Good day, everyone and welcome to Pfizer's Second Quarter 2014 Earnings Conference Call.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

The Washington Post

Pfizer CEO Is Impatient for Tax Reform as He Hunts for Deals

Failing to buy AstraZeneca Plc with the drug industry's largest-ever deal hasn't stopped Pfizer Inc.'s Ian Read from looking far and wide for acquisitions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, US News, US Politics, US Senate, Ron Wyden, Democrat, Carl Levin, Business News

Insider Monkey

Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan

Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc. has to go for some kind of acquisition to strengthen its pipeline and because of that, I think, Pfizer Inc. in May, when the latter turned down its $118 billion bid offer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Consulting, Frost and Sullivan, Merck

Business Journal

Accelerator Corp. raises $51M, will expand to New York

Acclerator Corp., a Seattle a life-science investment firm that focuses on biotech businesses, said it's raised $51.1 million in capital funding, and will expand to New York City.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer

TheStreet.com

U.S. Stocks Higher as Merck, Pfizer Top Expectations

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Financial Markets, Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla

Business Journal

Polaris names former Pfizer exec as area's first female VC partner

Helping reverse a nationwide trend of fewer female venture capitalists in recent years, Polaris Partners has named the only female partner currently at any of the area's top VC firms.

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••